Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
Jinglu Wang(Peking University), Zhenfeng Duan(University of Miami)
Cited by 208
Related Papers
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
|BMC Cancer|2009|161
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
|Scientific Reports|2015|156
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
|Oncotarget|2015|103